+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Insulin - Global Market Trajectory & Analytics

  • ID: 5303049
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Biocon Limited
  • Biodel, Inc.
  • Boston Scientific Corp.
  • Braun Melsungen AG
  • ELI Lilly and Company
  • Medtronic Plc
Global Human Insulin Market to Reach $102 Billion by 2027

Amid the COVID-19 crisis, the global market for Human Insulin estimated at US$49.9 Billion in the year 2020, is projected to reach a revised size of US$102 Billion by 2027, growing at a CAGR of 10.7% over the period 2020-2027. Analog, one of the segments analyzed in the report, is projected to record 11.2% CAGR and reach US$84.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Traditional segment is readjusted to a revised 8.9% CAGR for the next 7-year period.





The U.S. Market is Estimated at $13.5 Billion, While China is Forecast to Grow at 14.2% CAGR

The Human Insulin market in the U.S. is estimated at US$13.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$22 Billion by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 9.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Select Competitors (Total 43 Featured):
  • Becton, Dickinson and Company
  • Biocon Limited
  • Biodel, Inc.
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp.
  • Braun Melsungen AG
  • ELI Lilly and Company
  • Julphar (Also Known as Gulf Pharmaceutical Industries)
  • Medtronic Plc
  • Merck & Co., Inc.
  • NOVO Nordisk A/S
  • Sanofi
  • Tonghua Dongbao Pharmaceutical
  • Wockhardt Limited
  • Ypsomed AG
Frequently Asked Questions about the Global Market for Human Insulin

What is the estimated value of the Global Market for Human Insulin?

The Global Market for Human Insulin was estimated to be valued at $49.9 Billion in 2020.

What is the growth rate of the Global Market for Human Insulin?

The growth rate of the Global Market for Human Insulin is 10.8%, with an estimated value of $102.0 Billion by 2027.

What is the forecasted size of the Global Market for Human Insulin?

The Global Market for Human Insulin is estimated to be worth $102.0 Billion by 2027.

Who are the key companies in the Global Market for Human Insulin?

Key companies in the Global Market for Human Insulin include Becton, Dickinson and Company, Biocon Limited, Biodel, Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corp., Braun Melsungen AG, ELI Lilly and Company, Julphar (Also Known as Gulf Pharmaceutical Industries) and Merck & Co. Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocon Limited
  • Biodel, Inc.
  • Boston Scientific Corp.
  • Braun Melsungen AG
  • ELI Lilly and Company
  • Medtronic Plc

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION
  • Total Companies Profiled: 43
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Biocon Limited
  • Biodel, Inc.
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp.
  • Braun Melsungen AG
  • ELI Lilly and Company
  • Julphar (Also Known as Gulf Pharmaceutical Industries)
  • Medtronic Plc
  • Merck & Co. Inc.
  • NOVO Nordisk A/S
  • Sanofi
  • Tonghua Dongbao Pharmaceutical
  • Wockhardt Limited
  • Ypsomed AG
Note: Product cover images may vary from those shown